Nebraska

Psychedelic trials in Nebraska

10 registered trials has a study site in Nebraska, and 2 are recruiting now.

10

Trials with a site here

2

Recruiting

5

Facilities

Open now

Recruiting in this state

Trial	Status	Phase	Substance	Sites
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654 · COMPASS Pathways	Recruiting	Phase 2 / Phase 3	psilocybin	8
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, Denver	Recruiting	Phase 1	psilocybin	6

Facilities

Where the research happens in Nebraska

Facility	City	Trials
University of Nebraska Medical Center	Omaha	2
Alivation Research, LLC.	Lincoln	2
NE	Lincoln	1
VA Nebraska Western Iowa Health Care System	Omaha	1
Clinical Site 125	Lincoln	1

Stay told

When a trial opens in Nebraska

All trials

Every trial with a Nebraska site

Trial	Status	Phase	Substance	Sites
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654 · COMPASS Pathways	Recruiting	Phase 2 / Phase 3	psilocybin	8
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, Denver	Recruiting	Phase 1	psilocybin	6
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 · COMPASS Pathways	Completed	Phase 3	psilocybin	40
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 · COMPASS Pathways	Active, not recruiting	Phase 3	psilocybin	116
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · Usona Institute	Active, not recruiting	Phase 3	psilocybin	29
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionNCT02417064 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	90
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	173
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd.	Completed	Phase 2	ketamine	46
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal CancersNCT05220046 · University of Nebraska	Completed	Phase 1	psilocybin	1

Site locations from ClinicalTrials.gov API v2, data build 2026-10-06.

Elsewhere

Other states